Compound 1586
Identifiers
- Canonical SMILES:
CNC(=O)c1cccc(O[C@H](C)C(=O)N2CCN(C[C@H]2C)C(=O)c2ccccc2)c1
- IUPAC name:
3-[1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-1-oxopropan-2-yl]oxy-N-methylbenzamide
- InChi:
InChI=1S/C23H27N3O4/c1-16-15-25(23(29)18-8-5-4-6-9-18)12-13-26(16)22(28)17(2)30-20-11-7-10-19(14-20)21(27)24-3/h4-11,14,16-17H,12-13,15H2,1-3H3,(H,24,27)/t16-,17-/m1/s1
- InChiKey:
LUSNYUGJESXMCA-IAGOWNOFSA-N
External links
![]() 168317809 |
![]() 24634517 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD4 / gp120 | 5.85 | HIV infectious disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 409.20 g/mol | |||
HBA | 7 | |||
HBD | 1 | |||
HBA + HBD | 8 | |||
AlogP | 1.92 | |||
TPSA | 78.95 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6577 | Fipexide | DB13790 | |
0.6495 | Itopride | DB04924 | |
0.6355 | Troxipide | DB13419 | |
0.6316 | Flecainide | DB01195 | |
0.6238 | Trimethobenzamide | DB00662 | |
0.6186 | Tiropramide | DB13091 | |
0.6042 | Bavisant | DB12299 | |
0.5946 | N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE | DB07279 | |
0.5761 | Etamivan | DB08989 | |
0.5752 | Roxatidine acetate | DB08806 | |
0.5714 | OTX-008 | DB13123 | |
0.5619 | 4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE | DB08608 | |
0.5544 | Bunaftine | DB13652 | |
0.5524 | CC-220 | DB12101 | |
0.5454 | Bephenium | DB13462 |